Recombinant Mouse CASQ2 Protein，His

CASQ2, or Calsequestrin 2, is an important calcium-binding protein primarily found in cardiac and skeletal muscle cells, where it plays a critical role in calcium homeostasis and muscle contraction. Mutations in the CASQ2 gene have been linked to catecholaminergic polymorphic ventricular tachycardia (CPVT), a serious cardiac arrhythmia that can lead to syncope or sudden cardiac death, particularly in young individuals. The study of CASQ2 recombinant proteins offers insights into the biochemical and physiological functions of this protein, facilitating a better understanding of the molecular mechanisms underlying cardiac excitability and contractility. Research on CASQ2 is particularly relevant for developing therapeutic strategies to address CPVT and other calcium-related cardiac disorders. By producing and characterizing CASQ2 recombinant proteins, scientists can investigate the structural properties of the protein, its interaction with other calcium handling proteins, and the impact of specific mutations on its function. Furthermore, recombinant CASQ2 can be utilized in in vitro systems to evaluate drug interactions and potential treatments for heart rhythm disorders, making it a valuable tool in both basic and applied cardiovascular research. Understanding CASQ2 at the molecular level not only broadens our comprehension of cardiac physiology but also aids in the development of targeted therapies, thereby improving patient outcomes in those affected by cardiac arrhythmias associated with CASQ2 mutations.